Preview Mode Links will not work in preview mode

Nov 26, 2021

The articles are called “The new synthesis: How synthetic DNA technology is changing drug discovery” and “In vitro drug interaction data critical in drug repurposing”. The first was written by Dr Tim Brears, CEO of Evonetix and Dr Raquel Sanches-Kuiper, Director of Biology at Evonetix. The second was written by...


Nov 5, 2021

In the first article, DDW Editor Lu Rahman takes look at some of the latest imaging innovations available and how it can benefit drug target identification and drug discovery research.

In the second, Farah Patell-Socha, PhD, VP Research Products tells Lu Rahman about some of the company’s groundbreaking work in this...


Oct 25, 2021

The latest free-to-listen DDW podcast episode covers two articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine, narrated by DDW’s Megan Thomas. 

These articles are titled: “Antibody therapeutics: the other race for immunity against SARS-CoV2” and “Synthesising new...


Oct 15, 2021

Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and drug discovery and how high-throughput screening can help alleviate this. High throughput with multiplex is valuable for drug discovery and Wylie will provide insight on this as well offering...


Oct 8, 2021

Bamlanivimab was the first neutralising monoclonal antibody to receive emergency use authorisation from the FDA as a treatment for mild to moderate COVID-19 on 9 November 2020, 94 days after the monoclonal antibody discovery workflow began for the molecule. This achievement, says Eli Lilly, represents the shortest...